One to One names life sciences head

Share this article:

Digital marketing firm One to One Interactive has named Gayatri Bhalla group director of its life sciences division.

In her new role, Bhalla will be responsible for the strategic direction of the life science practice, which oversees interactive accounts for GlaxoSmithKline's Avandia, Advair, Wellbutrin, Lamictal (bipolar and epilepsy) and Valtrex, as well as Roche's transplantation franchise, including Cellcept and Zenapax.

“A shift is taking place in the consumer health space, as more and more people are actively engaging in the use of interactive mediums to validate trusted vendors and to make well-informed purchasing decisions,” Bhalla said. “I am pleased to offer my knowledge and insight.”

Bhalla has been in the life sciences area since 1997, working with GlaxoSmithKline, Pfizer and Millennium Pharmaceuticals. 

Share this article:
You must be a registered member of MMM to post a comment.
close

Next Article in Features

Email Newsletters

MM&M EBOOK: PATIENT ACCESS

Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.

More in Features

Read the complete September 2014 Digital Edition

Read the complete September 2014 Digital Edition

Click the above link to access the complete Digital Edition of the August 2014 issue of MM&M, with all text, charts and pictures.

Medical marketing needs mainstream Mad Men

Medical marketing needs mainstream Mad Men

Agencies must generate emotional resonance with the target audience, not unlike Apple, Pepsi or Nike

Are discounts cutting out co-pays?

GSK's decision to cut Advair's price spurred some PBMs to put it back on formulary. Will drugmaker discounts diminish the need for loyalty programs? How can these programs stay relevant beyond giving co-pay assistance?